BSESYSCHEM (INDIA) LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 27 Oct, 2026 · 14:45 IST

Syschem posts Q2 profit, but half-year net profit drops 93% to Rs 24 lakh

Negative Operating CashflowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+8.5%Reaction day
₹33.10
prior close
₹34.35
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+6.7% vs market
Pharmaceuticals peers, median of 173sector+2.0%+6.5% vs sector

On the reaction day the stock moved 6.7 pts more than Nifty Microcap 250 and 6.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+8.3
10m
+7.5
15m
+2.5
30m
+6.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+8.5+1.7+6.7+2.0+6.5
Next day
+11.4+1.8+9.6+2.6+8.7
2d
+8.0+2.5+5.5+2.6+5.4
3d
+0.5pendingpending+2.0-1.6
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited results for the quarter and half year ended 30 September 2026. Quarter revenue rose about 10% to Rs 12,979 lakh and net profit edged up to Rs 191 lakh, after a Rs 167 lakh loss in the June quarter. Half-year revenue rose 5% to Rs 25,574 lakh, but net profit fell 93% to Rs 24 lakh from Rs 357 lakh. Operating cash outflow widened to Rs 1,957 lakh.

Likely market impact

Quarterly recovery is weak, while half-year earnings and cash flow are much weaker, so stock sentiment may remain subdued.